Al-Shawi Marwan K, Omote Hiroshi
Department of Molecular Physiology and Biological Physics, University of Virginia Health System, P.O. Box 800736, Charlottesville, Virginia, 22908-0736, USA.
J Bioenerg Biomembr. 2005 Dec;37(6):489-96. doi: 10.1007/s10863-005-9497-5.
Human P-glycoprotein (ABCB1) is a primary multidrug transporter located in plasma membranes, that utilizes the energy of ATP hydrolysis to pump toxic xenobiotics out of cells. P-glycoprotein employs a most unusual molecular mechanism to perform this drug transport function. Here we review our work to elucidate the molecular mechanism of drug transport by P-glycoprotein. High level heterologous expression of human P-glycoprotein, in the yeast Saccharomyces cerevisiae, has facilitated biophysical studies in purified proteoliposome preparations. Development of novel spin-labeled transport substrates has allowed for quantitative and rigorous measurements of drug transport in real time by EPR spectroscopy. We have developed a new drug transport model of P-glycoprotein from the results of mutagenic, quantitative thermodynamic and kinetic studies. This model satisfactorily accounts for most of the unusual kinetic, coupling, and physiological features of P-glycoprotein. Additionally, an atomic detail structural model of P-glycoprotein has been devised to place our results within a proper structural context.
人类P-糖蛋白(ABCB1)是一种主要的多药转运蛋白,位于质膜中,利用ATP水解产生的能量将有毒的外源性物质泵出细胞。P-糖蛋白采用一种非常独特的分子机制来执行这种药物转运功能。在此,我们回顾我们的工作,以阐明P-糖蛋白药物转运的分子机制。人类P-糖蛋白在酿酒酵母中的高水平异源表达,促进了对纯化的蛋白脂质体制剂的生物物理研究。新型自旋标记转运底物的开发,使得通过电子顺磁共振光谱实时定量和严格测量药物转运成为可能。我们根据诱变、定量热力学和动力学研究结果,开发了一种新的P-糖蛋白药物转运模型。该模型令人满意地解释了P-糖蛋白的大多数异常动力学、偶联和生理特征。此外,还设计了P-糖蛋白的原子细节结构模型,以便将我们的结果置于适当的结构背景中。